amrinone has been researched along with Cholera Infantum in 2 studies
Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.
Excerpt | Relevance | Reference |
---|---|---|
"Clinical trials of intravenous amrinone were performed in 462 patients severely ill with congestive heart failure." | 5.05 | Clinical safety of intravenous amrinone--a review. ( Treadway, G, 1985) |
" Adverse effects are minimal, with dosage limited predominantly by decreases in filling pressures." | 2.37 | Intravenous use of amrinone for the treatment of the failing heart. ( LeJemtel, T; Mancini, D; Sonnenblick, E, 1985) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mancini, D | 1 |
LeJemtel, T | 1 |
Sonnenblick, E | 1 |
Treadway, G | 1 |
1 review available for amrinone and Cholera Infantum
Article | Year |
---|---|
Intravenous use of amrinone for the treatment of the failing heart.
Topics: Aminopyridines; Amrinone; Cardiac Complexes, Premature; Cardiac Output; Cardiotonic Agents; Drug Int | 1985 |
1 trial available for amrinone and Cholera Infantum
Article | Year |
---|---|
Clinical safety of intravenous amrinone--a review.
Topics: Aminopyridines; Amrinone; Arrhythmias, Cardiac; Cardiotonic Agents; Clinical Trials as Topic; Drug I | 1985 |